Research information only — not medical advice. Full disclaimer
Peptide Library

Peptide profile

Metabolic Anecdotal

MOTS-c

Mitochondrial-encoded peptide for glucose control

Compare MOTS-c with other peptides →

Summary

Mitochondrial-derived peptide for metabolic regulation & insulin sensitivity.

A tiny protein from your cells' powerhouses. It helps your body use sugar and energy.

Typical dose
5-10mg Daily
Route
Subcutaneous
Cycle length
30-60 days
Evidence
Anecdotal

Mechanism

How it works

MOTS-c acts like a text message from your mitochondria to your cell's nucleus — it reports energy status and triggers metabolic adjustments.

MOTS-c is a mitochondrial-derived peptide encoded in 12S rRNA that activates AMPK, improving insulin sensitivity and metabolic flexibility.

MOTS-c is a mitochondrial-derived peptide encoded in 12S rRNA that activates AMPK, improving insulin sensitivity and metabolic flexibility.

Reported in research

Benefits

  • Improves insulin sensitivity
  • Increases metabolic rate
  • Reduces age-related weight gain
  • Enhances physical endurance
  • Helps your body use sugar better
  • Helps your body burn energy faster
  • Helps stop weight gain as you get older
  • Helps you exercise longer without getting tired

Context, not a prescription

Dosing

Typical range
5-10mg Daily (Subcutaneous)
Cycle length
30-60 days

Safety

Side effects & contraindications

Possible side effects

  • Injection site redness
  • Mild nausea
  • Temporary fatigue
  • Headache
  • Dizziness
  • Flushing

Contraindications

  • Pregnancy or breastfeeding
  • Severe hypoglycemia
  • Known hypersensitivity

Research information, not medical advice. Always consult a licensed clinician before considering any peptide.

In depth

Full profile

What it does

Your body uses sugar better, burns energy faster, and loses fat.

How it works

MOTS-c is like a text message. Your cell powerhouses send it to the cell's brain. It says how much energy you have and asks for changes.

It goes into the control center of your cells. There it tells your body how to use sugar and energy.

What to expect

You may notice changes in your energy use in 2 to 4 weeks.

  • Weeks 1-2: Your body starts using energy a little better.
  • Weeks 3-4: Your body uses sugar better.
  • Weeks 6-8: You slowly lose fat and can exercise longer.

Good to know

  • Start with a smaller amount (5mg)
  • Check your blood sugar
  • Take breaks between using it

Staying safe

  • Red skin where you got the shot
  • Feeling a little sick to your stomach
  • Feeling tired for a short time

Avoid if you have:

  • Moms who are pregnant or breastfeeding
  • People whose blood sugar drops very low
  • People allergic to it

Overview

Improved insulin sensitivity, increased metabolic rate, reduced fat mass.

How it works

MOTS-c acts like a text message from your mitochondria to your cell's nucleus — it reports energy status and triggers metabolic adjustments.

Enters nucleus to regulate gene expression for metabolic adaptation and glucose homeostasis.

Onset & timeline

Metabolic effects within 2-4 weeks.

  • Weeks 1-2: Improved metabolic markers.
  • Weeks 3-4: Enhanced insulin sensitivity.
  • Weeks 6-8: Progressive fat loss and endurance.

Getting the most from it

  • Start with lower dose (5mg)
  • Monitor blood glucose
  • Cycle with breaks

Common side effects

  • Injection site redness
  • Mild nausea
  • Temporary fatigue

Mechanism of action

MOTS-c is a mitochondrial-derived peptide encoded in 12S rRNA that activates AMPK, improving insulin sensitivity and metabolic flexibility.

Enters nucleus to regulate gene expression for metabolic adaptation and glucose homeostasis.

Pharmacodynamics

Metabolic effects within 2-4 weeks.

Improved insulin sensitivity, increased metabolic rate, reduced fat mass.

Timeline

  • Weeks 1-2: Improved metabolic markers.
  • Weeks 3-4: Enhanced insulin sensitivity.
  • Weeks 6-8: Progressive fat loss and endurance.

Comparisons

  • MOTS-c — effectiveness Emerging, safety Emerging, cost $$, Medium to use
  • Metformin — effectiveness High, safety Good, cost $, Easy to use

Adverse effects

Common:

  • Injection site redness
  • Mild nausea
  • Temporary fatigue

Rare:

  • Headache
  • Dizziness
  • Flushing

Contraindications & risk mitigation

Contraindicated in:

  • Pregnancy or breastfeeding
  • Severe hypoglycemia
  • Known hypersensitivity
  • Start with lower dose (5mg)
  • Monitor blood glucose
  • Cycle with breaks

Qué hace

Tu cuerpo utiliza mejor el azúcar, quema energía más rápido y pierde grasa.

Cómo funciona

MOTS-c es como un mensaje de texto. Las centrales energéticas de tus células lo envían al 'cerebro' de la célula. Indica cuánta energía tienes y solicita ajustes.

Llega al centro de control de tus células. Allí le indica a tu cuerpo cómo utilizar el azúcar y la energía.

Qué esperar

Puedes notar cambios en tu uso de energía en 2 a 4 semanas.

  • Semanas 1-2: Tu cuerpo comienza a utilizar la energía un poco mejor.
  • Semanas 3-4: Tu cuerpo utiliza mejor el azúcar.
  • Semanas 6-8: Pierdes grasa lentamente y puedes ejercitarte más tiempo.

Bueno saber

  • Comenzar con una dosis menor (5 mg)
  • Revisar tu azúcar en sangre
  • Tomar descansos entre ciclos de uso

Manteniéndose seguro

  • Enrojecimiento en la zona de la inyección
  • Sentir un poco de náuseas
  • Sentirse cansado por un corto tiempo

Evitar si tienes:

  • Mujeres embarazadas o en lactancia
  • Personas con niveles muy bajos de azúcar en sangre
  • Personas alérgicas a este péptido

Descripción general

Mejora de la sensibilidad a la insulina, aumento de la tasa metabólica y reducción de la masa grasa.

Cómo funciona

MOTS-c actúa como un mensaje de texto desde tus mitocondrias al núcleo de tu célula: informa sobre el estado energético y desencadena ajustes metabólicos.

Ingresa al núcleo para regular la expresión génica adaptativa y la homeostasis de la glucosa.

Inicio y cronología

Efectos metabólicos en 2-4 semanas.

  • Semanas 1-2: Mejora de los marcadores metabólicos.
  • Semanas 3-4: Mayor sensibilidad a la insulina.
  • Semanas 6-8: Pérdida de grasa progresiva y mejora de la resistencia.

Cómo aprovecharlo al máximo

  • Comenzar con dosis baja (5 mg)
  • Monitorear la glucosa en sangre
  • Realizar ciclos con pausas

Efectos secundarios comunes

  • Enrojecimiento en el sitio de inyección
  • Náuseas leves
  • Fatiga temporal

Mecanismo de acción

MOTS-c es un péptido derivado de mitocondrias codificado en 12S rRNA que activa AMPK, mejorando la sensibilidad a la insulina y la flexibilidad metabólica.

Ingresa al núcleo para regular la expresión génica adaptativa y la homeostasis de la glucosa.

Farmacodinamia

Efectos metabólicos en 2-4 semanas.

Mejora de la sensibilidad a la insulina, aumento de la tasa metabólica y reducción de la masa grasa.

Cronología

  • Semanas 1-2: Mejora de los marcadores metabólicos.
  • Semanas 3-4: Mayor sensibilidad a la insulina.
  • Semanas 6-8: Pérdida de grasa progresiva y mejora de la resistencia.

Comparaciones

  • MOTS-c — efectividad Emergente, seguridad Emergente, costo $$, Media de usar
  • Metformina — efectividad Alta, seguridad Buena, costo $, Fácil de usar

Efectos adversos

Comunes:

  • Enrojecimiento en el sitio de inyección
  • Náuseas leves
  • Fatiga temporal

Raros:

  • Dolor de cabeza
  • Mareos
  • Enrojecimiento

Contraindicaciones y mitigación de riesgos

Contraindicado en:

  • Embarazo o lactancia
  • Hipoglucemia severa
  • Hipersensibilidad conocida
  • Comenzar con dosis baja (5 mg)
  • Monitorear la glucosa en sangre
  • Realizar ciclos con pausas

Reference data

Specifications

Route
Subcutaneous
Cycle length
30-60 days

FAQ

Common questions

Is MOTS-c naturally occurring?

Yes, it is encoded in the mitochondrial genome.

Does MOTS-c help with type 2 diabetes?

Animal studies show improved glucose tolerance; human research is ongoing.

What is the evidence level?

This compound is classified as Anecdotal. Evidence relies primarily on self-reported user experiences. Controlled studies are lacking.

Research

Research & sources

Anecdotal

Current evidence for MOTS-c is rated as Anecdotal. No controlled clinical research is available.

  1. 1. MOTS-c and metabolism (2015) — DOI:10.1016/j.cmet.2015.02.009
  2. 2. Mitochondrial peptides review (2021) — DOI:10.1038/s41580-020-00323-5
  3. 3. MOTS-c and metabolism (2015)
  4. 4. Mitochondrial peptides review (2021)